CRi Names Darren Lee Vice President of Marketing

New position reflects CRi’s continued growth in 2010.

Woburn, Massachusetts June 22, 2010 -

masscapmugshot

Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, today announced the appointment of Darren Lee as the company’s vice president of marketing. He will be responsible for leading all strategic marketing activities for the company’s products and sales across the United States and worldwide.

“CRi’s technology is positioned to lead the emerging field of tissue-based multiplexed analysis from basic research through diagnostics,” said Lee. “I’m excited about the opportunity to help drive growth in these key segments, further enabling our customers to more rapidly identify and validate biomarkers of disease, leading to new therapeutics and companion diagnostics.”

Lee comes to CRi with more than 20 years of experience in marketing management, business development and engineering in the life sciences and clinical diagnostics industries.

“Darren’s extensive experience and proven leadership in the field of biotechnology will be a tremendous asset,” said George Abe, president and chief executive officer of CRi. “We are excited to add him to our management team and believe his expertise will contribute greatly to the continued development of the company.”

Lee has held senior-level management positions at Primera Biosystems, a molecular diagnostics company, and Decision Biomarkers, a life-science systems developer. He has also served in senior management positions at PerkinElmer and Packard Bioscience. He has a B.S. in Biomedical Engineering Technology from Temple University and an M.S. in Technology Management from Pepperdine University.

About CRi, Inc.

Cambridge Research & Instrumentation, Inc. (CRi) develops and markets optical imaging systems to advance biomedical research and molecular-based drug and diagnostic development. CRi’s patented systems enable researchers and clinicians to quantitate multiple disease and drug response markers in intact tissue samples, at a cellular level or in living small animals. CRi’s products integrate a unique multispectral imaging technology with proprietary image analysis algorithms to achieve unparalleled accuracy and sensitivity, rapidly and cost-effectively. CRi’s award-winning systems include Nuance™ for multispectral imaging on brightfield and fluorescence microscopes; inForm™ automated image analysis software; Vectra™ for high-throughput slide imaging and analysis; and Maestro™ for in-vivo optical imaging. Learn more at www.cri-inc.com.

For more information, contact:

Cambridge Research & Instrumentation, Inc. (CRi)

Cathy Boutin

781-935-9099

Marketing Manager

cboutin@cri-inc.com

Commonwealth Creative Associates

Jamie Bull

508-620-0791

Digital Media Strategist

jamieb@commcreative.com

Commonwealth Creative Associates